Content Block Tag: NRG-LU006: Malignant Pleural Mesothelioma Study

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

NRG-LU006 FAQ

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Quick Information Find a study location Are you interested in joining this study? Find a Participating Location Want more information? Additional information for the NRG Oncology LU006 trial can be found in the Patient Study Brochure Download Brochure

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

About This Study NRG-GI004/SWOG-S1610 is a clinical trial that is studying two treatment options for patients with colorectal cancer that has spread to other parts of their body (metastatic). This study is specifically for patients who have a particular type of metastatic colorectal cancer called “MSI-high” or “DNA repair deficient” (these two terms are sometimes […]

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Am I eligible for this study? Men or women may be able to participate if they have colorectal cancer that is known to have a specific alteration that may or may not be hereditary (MSI-high/DNA mismatch repair deficient), has spread to other parts of their body (metastatic), and they have not yet received treatment for […]

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

Am I eligible for this study? If you have newly diagnosed malignant pleural mesothelioma and have not yet been treated or have only been treated with chemotherapy or immunotherapy, and you are a candidate for the type of surgery used in this trial called a pleurectomy / decortication, you may be able to participate. Your […]

‘Text/HTML’ of page ‘NRG-LU006: Malignant Pleural Mesothelioma Study’

About This Study NRG-LU006 was a clinical trial studying whether adding targeted radiation therapy called IMPRINT to the usual treatment of surgery and systemic therapy with chemotherapy or immune therapy, can help to extend the life of people with malignant pleural mesothelioma (MPM). MPM is a tumor of the tissue that lines the surface […]